Krka, d. d. (WSE: KRK)

Market Cap	20.76B
Revenue (ttm)	8.14B
Net Income (ttm)	1.54B
Shares Out	n/a
EPS (ttm)	49.99
PE Ratio	13.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jul 23, 2024

Volume	80
Average Volume	105
Open	650.00
Previous Close	650.00
Day's Range	650.00 - 674.00
52-Week Range	492.00 - 674.00
Beta	0.53
RSI	81.17
Earnings Date	Jan 30, 2025

About Krka, d. d.

Krka, d. d. develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for cardiovascular, central nervous system, gastrointestinal tract, pain relief, diabetes, blood and blood-forming organs, anti-infectives for systemic use, oncology, and other applications. The company also provides non-prescription products, such as cough and cold pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 10,284
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2023, Krka, d. d.'s revenue was 1.81 billion, an increase of 5.18% compared to the previous year's 1.72 billion. Earnings were 313.95 million, a decrease of -13.58%.

Financial numbers in EUR